105 related articles for article (PubMed ID: 9431023)
1. Synthesis and structure elucidation of 5-aminomethinimino-3-methyl-4-isoxazolecarboxylic acid phenylamides and their immunological activity.
Ryng S; Machoń Z; Wieczorek Z; Zimecki M; Głowiak T
Arch Pharm (Weinheim); 1997 Nov; 330(11):319-26. PubMed ID: 9431023
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and immunological activity of new 5-amino-3-methyl 4-amido and 4-ureilene isoxazole derivatives.
Ryng S; Machoń Z; Wieczorek Z; Zimecki M
Pharmazie; 1999 May; 54(5):359-61. PubMed ID: 10368829
[TBL] [Abstract][Full Text] [Related]
3. Structure and immunological activity of disubstituted thiosemicarbazide isoxazole derivative.
Maczyński M; Zimecki M; Ryng S
Acta Pol Pharm; 2004 Dec; 61 Suppl():82-3. PubMed ID: 15909949
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulating action and structure-activity relationships of substituted phenylamides of 5-amino-3-methylisoxazole-4-carboxylic acid.
Ryng S; Zimecki M; Sonnenberg Z; Mokrosz MJ
Arch Pharm (Weinheim); 1999 May; 332(5):158-62. PubMed ID: 10366900
[TBL] [Abstract][Full Text] [Related]
5. Search for new lead structures for low-molecular-weight immune response modifiers.
Ryng S; Zimecki M
Acta Pol Pharm; 2004 Dec; 61 Suppl():78-81. PubMed ID: 15909948
[TBL] [Abstract][Full Text] [Related]
6. A new class of isoxazole derivatives: the M 1-9 series of compounds with immunotropic activity.
Maczyński M; Zimecki M; Ryng S
Acta Pol Pharm; 2008; 65(2):241-4. PubMed ID: 18666432
[TBL] [Abstract][Full Text] [Related]
7. Immunological activity of new heterocyclic amides of 5-amino-3-methylisoxazole-4-carboxylic acid.
Ryng S; Zimecki M; Fedorowicz A; Koll A
Pol J Pharmacol; 1999; 51(3):257-62. PubMed ID: 10600040
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytostatic properties of 5-substituted derivatives of 3-methylisoxazolo[5,4-d]1,2,3-triazine-4-ones and 3-methyl-5-triazene 4-isoxazolecarboxylic acid ethyl esters.
Ryng S; Malinka W; Duś D
Farmaco; 1997 Feb; 52(2):105-8. PubMed ID: 9181691
[TBL] [Abstract][Full Text] [Related]
9. SYNTHESIS AND IMMUNOREGULATORY PROPERTIES OF SELECTED 5-AMINO-3-METHYL-4-ISOXAZOLECARBOXYLIC ACID BENZYLAMIDES.
Maczynski M; Artym J; Kocieba M; Sockacka-Cwikla A; Drozd-Szczygiel E; Ryng S; Zimecki M
Acta Pol Pharm; 2016 Sep; 73(5):1201-1211. PubMed ID: 29638060
[TBL] [Abstract][Full Text] [Related]
10. The effect of 5-amino-3-methyl-4-isoxazolecarboxylic acid hydrazide on lymphocyte subsets and humoral immune response in SRBC-immunized mice.
Drynda A; Obmińska-Mrukowicz B; Mączyński M; Ryng S
Immunopharmacol Immunotoxicol; 2015 Apr; 37(2):148-57. PubMed ID: 25572572
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, immunological activity and computational study of 5-amino-3-methyl-4-isoxazolecarboxylic acid semicarbazides and thiosemicarbazides.
Maczyński M; Zimecki M; Taraszkiewicz M; Ryng S
Acta Pol Pharm; 2008; 65(5):543-9. PubMed ID: 19051600
[TBL] [Abstract][Full Text] [Related]
12. Syntheses of novel 3-amino-2(1H)-thioxo-4(3H)-quinazolinones and evaluation of their immunotropic activity. Part III.
Nawrocka W; Zimecki M
Arch Pharm (Weinheim); 1997 Dec; 330(12):399-405. PubMed ID: 9474900
[TBL] [Abstract][Full Text] [Related]
13. 5-Amino-3-methyl-4-isoxazolecarboxylic acid hydrazide derivatives with in vitro immunomodulatory activities.
Drynda A; Obmińska-Mrukowicz B; Zaczyńska E; Zimecki M; Kochanowska I; Ryng S; Mączyński M
Chem Biol Drug Des; 2017 May; 89(5):705-713. PubMed ID: 27779824
[TBL] [Abstract][Full Text] [Related]
14. Search for new lead structures in the isoxazole heterocyclic system.
Ryng S; Zimecki M; Fedorowicz A; Jezierska A; Głowiak T
Acta Pol Pharm; 2003; 60(3):225-8. PubMed ID: 14556494
[TBL] [Abstract][Full Text] [Related]
15. In vitro immunomodulatory effects of 5-amino-3-methyl-4-isoxazolecarboxylic acid hydrazide on the cellular immune response.
Drynda A; Mączyński M; Ryng S; Obmińska-Mrukowicz B
Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):150-7. PubMed ID: 24588616
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists.
Xin Z; Zhao H; Serby MD; Liu B; Schaefer VG; Falls DH; Kaszubska W; Colins CA; Sham HL; Liu G
Bioorg Med Chem Lett; 2005 Feb; 15(4):1201-4. PubMed ID: 15686942
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of 4,5-dihydro-5-methylisoxazolin-5-carboxamide derivatives as VLA-4 antagonists.
Soni A; Rehman A; Naik K; Dastidar S; Alam MS; Ray A; Chaira T; Shah V; Palle VP; Cliffe IA; Sattigeri VJ
Bioorg Med Chem Lett; 2013 Mar; 23(5):1482-5. PubMed ID: 23312947
[TBL] [Abstract][Full Text] [Related]
18. New amides of 5-acylamino-3-methyl-4-isothiazolecarboxylic acid and their immunotropic activity.
Lipnicka U; Regiec A; Sułkowski E; Zimecki M
Arch Pharm (Weinheim); 2005 Jul; 338(7):322-8. PubMed ID: 15952244
[TBL] [Abstract][Full Text] [Related]
19. The 5-amino-3-methyl-4-ureidoisoxazoles, synthesis and antileucemic activity.
Ryng S; Duś D
Pharmazie; 1994 Oct; 49(10):727-9. PubMed ID: 7816898
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and immunostimulatory activity of substituted TLR7 agonists.
Akinbobuyi B; Wang L; Upchurch KC; Byrd MR; Chang CA; Quintana JM; Petersen RE; Seifert ZJ; Boquin JR; Oh S; Kane RR
Bioorg Med Chem Lett; 2016 Sep; 26(17):4246-9. PubMed ID: 27476423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
